Company intelligence / Profile preview

Denovium

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Denovium did not develop its own therapeutics; it provided an AI platform and services for gene discovery, protein engineering, and genomic medicine, so there are no clinical trial results or internal drug pipeline to report.[3][5]

Industry: Drug Discovery Services

Partnerships

Maxygen (strategic partnership applying Denovium’s AI platform to Maxygen’s molecular breeding/directed evolution technology)[5]

Beyond the preview

Go deeper on Denovium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denovium.

Explore the full profile